• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form SC 13D/A filed by PureCycle Technologies Inc.

    9/17/24 11:35:20 AM ET
    $PCT
    Major Chemicals
    Industrials
    Get the next $PCT alert in real time by email
    SC 13D/A 1 pcta2_91724.htm SYLEBRA CAPITAL LLC pcta2_91724.htm
    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    SCHEDULE 13D
    Under the Securities Exchange Act of 1934
    (Amendment No. 2)*
    PureCycle Technologies, Inc.
    (Name of Issuer)
    Common Stock
    (Title of Class of Securities)
    74623V103
    (CUSIP Number)
    Matthew Whitehead, Chief Operating Officer / Authorized Signatory
    3000 El Camino Real, Building 5, Suite 450
    Palo Alto, CA 94306
    +1 332 242 8518
    (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
    September 13, 2024
    (Date of Event which Requires Filing of this Statement)
    If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. [X]
    * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page
    The information required on the remainder of this cover page shall not be deemed to be filed for the purposes of Section 18 of the Securities Exchange Act of 1934 (the Act) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Instructions).
    CUSIP No.: 74623V103
        
    1
    NAME OF REPORTING PERSON:
    Sylebra Capital LLC
    I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)
    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
    [   ] (a)
    [   ] (b)
    3 SEC USE ONLY
     
    4 SOURCE OF FUNDS:
    WC
    5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)
    [   ]
    6 CITIZENSHIP OR PLACE OF ORGANIZATION
    Delaware, US
    NUMBER OF SHARES
    BENEFICIALLY OWNED
    BY EACH REPORTING
    PERSON WITH
    7 SOLE VOTING POWER
    8 SHARED VOTING POWER
    33,457,649
    9 SOLE DISPOSITIVE POWER
    10 SHARED DISPOSITIVE POWER
    33,457,649
    11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
    33,457,649
    12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
    [   ]
    13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
    19.29%
    14 TYPE OF REPORTING PERSON
    HC, IA
    CUSIP No.: 74623V103
        
    1
    NAME OF REPORTING PERSON:
    Sylebra Capital Limited
    I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)
    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
    [   ] (a)
    [   ] (b)
    3 SEC USE ONLY
     
    4 SOURCE OF FUNDS:
    WC
    5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)
    [   ]
    6 CITIZENSHIP OR PLACE OF ORGANIZATION
    Hong Kong
    NUMBER OF SHARES
    BENEFICIALLY OWNED
    BY EACH REPORTING
    PERSON WITH
    7 SOLE VOTING POWER
    8 SHARED VOTING POWER
    33,457,649
    9 SOLE DISPOSITIVE POWER
    10 SHARED DISPOSITIVE POWER
    33,457,649
    11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
    33,457,649
    12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
    [   ]
    13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
    19.29%
    14 TYPE OF REPORTING PERSON
    HC, IA
    CUSIP No.: 74623V103
        
    1
    NAME OF REPORTING PERSON:
    Sylebra Capital Management
    I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)
    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
    [   ] (a)
    [   ] (b)
    3 SEC USE ONLY
     
    4 SOURCE OF FUNDS:
    WC
    5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)
    [   ]
    6 CITIZENSHIP OR PLACE OF ORGANIZATION
    Cayman Islands
    NUMBER OF SHARES
    BENEFICIALLY OWNED
    BY EACH REPORTING
    PERSON WITH
    7 SOLE VOTING POWER
    8 SHARED VOTING POWER
    33,457,649
    9 SOLE DISPOSITIVE POWER
    10 SHARED DISPOSITIVE POWER
    33,457,649
    11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
    33,457,649
    12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
    [   ]
    13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
    19.29%
    14 TYPE OF REPORTING PERSON
    HC, IA
    CUSIP No.: 74623V103
        
    1
    NAME OF REPORTING PERSON:
    Daniel Patrick Gibson
    I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)
    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
    [   ] (a)
    [   ] (b)
    3 SEC USE ONLY
     
    4 SOURCE OF FUNDS:
    WC
    5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)
    [   ]
    6 CITIZENSHIP OR PLACE OF ORGANIZATION
    Antigua and Barbuda
    NUMBER OF SHARES
    BENEFICIALLY OWNED
    BY EACH REPORTING
    PERSON WITH
    7 SOLE VOTING POWER
    714,300
    8 SHARED VOTING POWER
    33,600,549
    9 SOLE DISPOSITIVE POWER
    714,300
    10 SHARED DISPOSITIVE POWER
    33,600,549
    11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
    34,314,849
    12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
    [   ]
    13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
    19.78%
    14 TYPE OF REPORTING PERSON
    IN
    CUSIP No.: 74623V103
    ITEM 1. SECURITY AND ISSUER:
    This Amendment No. 2 on Schedule 13D/A (this "Amendment") amends the Schedule 13D filed by the Reporting Persons with the Securities and Exchange Commission on March 24, 2022, as amended from time to time (the "Schedule 13D"), relating to the shares of common stock, par value $0.001 per share ("Common Stock"), of PureCycle Technologies, Inc., a Delaware corporation (the "Issuer") with a class of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). The principal executive offices of the Issuer are located at 4651 Salisbury Road, Suite 400, Jacksonville, Florida 32256. Except as specifically provided herein, this Amendment does not modify any of the information previously reported in the Schedule 13D. Unless otherwise indicated herein, capitalized terms used but not defined in this Amendment shall have the same meanings herein as are ascribed to such terms in the Schedule 13D.
    ITEM 2. IDENTITY AND BACKGROUND:
    Sylebra Capital LLC ("Sylebra US") hereby files this Statement on behalf of the Reporting Persons pursuant to the Agreement with Respect to Schedule 13D (the "Joint Filing Agreement") attached to this Statement as Exhibit 99.1.

    Sylebra US and Sylebra Capital Limited ("Sylebra HK") are the investment sub-advisers to Sylebra Capital Partners Master Fund, Ltd. ("SCP MF"), Sylebra Capital Parc Master Fund ("PARC MF"), Sylebra Capital Menlo Master Fund ("MENLO MF") and other advisory clients. The term Affiliated Investment Entities refers to SCP MF, PARC MF, MENLO MF and other advisory clients. Sylebra Capital Management ("Sylebra Cayman") is the investment manager and parent of Sylebra HK. Sylebra Cayman owns 100% of the shares of Sylebra HK, and Daniel Patrick Gibson ("Gibson") owns 100% of the Class A shares of Sylebra Cayman and 100% of the share capital of Sylebra US. Gibson is a founder and Chief Investment Officer of Sylebra Cayman. In such capacities, Sylebra HK, Sylebra US, Sylebra Cayman, and Gibson may be deemed to share voting and dispositive power over the shares of common stock of the Issuer held by the Affiliated Investment Entities.

    Sylebra US, Sylebra HK, Sylebra Cayman and Gibson are each referred to herein individually as a Reporting Person and collectively as the Reporting Persons.

    The principal address of the Reporting Persons is c/o Sylebra Capital LLC, 3000 El Camino Real, Building 5, Suite 450, Palo Alto, CA 94306.

    Each of Sylebra US, Sylebra HK and Sylebra Cayman are engaged in the principal business of fund management. Gibson serves as (i) a director and owner of each Sylebra HK and Sylebra Cayman and (ii) a sole member of Sylebra US. Each of the Affiliated Investment Entities are engaged in the principal business of investments.
    None of the Reporting Persons have been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors) during the last 5 years.

    None of the Reporting Persons have during the last 5 years been party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.

    Sylebra US is a limited liability company organized under the laws of Delaware, United States. Sylebra HK is a private limited company organized under the laws of Hong Kong. Sylebra Cayman is an exempted company with limited liability organized under the laws of the Cayman Islands. Gibson is a citizen of Antiqua and Barbuda.
    ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION:
    The Reporting Persons each used their respective working capital to purchase the shares of common stock of the Issuer.
    ITEM 4. PURPOSE OF TRANSACTION:
    The purpose of the transactions was to acquire the shares of common stock of the Issuer for investment purposes with the aim of increasing the value of the investment and the Issuer.

    On September 11, 2024, each of the Affiliated Investment Entities entered into subscription agreements (the "Subscription Agreements") with the Issuer, pursuant to which the Issuer agreed to sell to such parties, in a private placement, an aggregate of 4,264,393 shares of the Issuer's Common Stock, 25,000 shares of the Issuers Series A Preferred Stock, and Series C Warrants to purchase an aggregate of 2,500,000 shares of the Issuers Common Stock. The shares of Series A Preferred Stock are not convertible into shares of the Issuer's Common Stock. The Series C Warrants will be exercisable beginning on the date of issuance, subject to a stock ownership restriction pursuant to which the Series C Warrants cannot be exercised by the Reporting Persons if such exercise would cause their beneficial ownership of the Issuer's Common Stock to exceed 19.9%. Pursuant to the Subscription Agreements, the Issuer is required to prepare and file a registration statement with the Securities and Exchange Commission under the Securities Act of 1933, as amended, covering the resale of the shares of the Issuer's Common Stock and the shares of the Issuer's Series A Preferred Stock issued pursuant to the Subscription Agreements and the resale of the shares of the Issuer's Common Stock underlying the Series C Warrants. The transactions subject to the Subscription Agreements closed on September 13, 2024.

    Subject to applicable legal requirements, one or more of the Reporting Persons may purchase additional securities of the Issuer from time to time in open market or private transactions, depending on their evaluation of the Issuer's business, prospects and financial condition, the market for the Issuer's securities, other developments concerning the Issuer, the reaction of the Issuer to the Reporting Persons ownership of the Issuer's securities, other opportunities available to the Reporting Persons, and general economic, money market and stock market conditions. In addition, depending upon the factors referred to above, the Reporting Persons may dispose of all or a portion of their securities of the Issuer at any time. Each of the Reporting Persons reserves the right to increase or decrease its holdings on such terms and at such times as each may decide.

    Other than as described above in this Item 4, none of the Reporting Persons have any plan or proposal relating to or that would result in: (a) the acquisition by any person of additional securities of the Issuer or the disposition of securities of the Issuer; (b) an extraordinary corporate transaction, such as a merger, reorganization or liquidation, involving the Issuer or any of its subsidiaries; (c) a sale or transfer of a material amount of assets of the Issuer or any of its subsidiaries; (d) any change in the present board of directors or management of the Issuer, including any plans or proposals to change the number or terms of directors or to fill any existing vacancies on the Board of Directors of the Issuer; (e) any material change in the present capitalization or dividend policy of the Issuer; (f) any other material change in the Issuers business or corporate structure; (g) any changes in the Issuers charter, by-laws or instruments corresponding thereto or other actions which may impede the acquisition of control of the Issuer by any person; (h) a class of securities of the Issuer being delisted from a national securities exchange or ceasing to be authorized to be quoted in an inter-dealer quotation system of a registered national securities association; (i) a class of equity securities of the Issuer becoming eligible for termination of registration pursuant to Section 12(g)(4) of the Exchange Act; or (j) any action similar to those enumerated above.
    ITEM 5. INTEREST IN SECURITIES OF THE ISSUER:
    (a)(b)
    Reporting Person: Sylebra Capital LLC (2)
    Shares Held Directly: --
    Sole Voting Power: --
    Shared Voting Power: 33,457,649
    Sole Dispositive Power: --
    Shared Dispositive Power: 33,457,649
    Beneficial Ownership: 33,457,649
    Percentage of Class: 19.29%(1)

    Reporting Person: Sylebra Capital Limited (3)
    Shares Held Directly: --
    Sole Voting Power: --
    Shared Voting Power: 33,457,649
    Sole Dispositive Power: --
    Shared Dispositive Power: 33,457,649
    Beneficial Ownership: 33,457,649
    Percentage of Class: 19.29%(1)

    Reporting Person: Sylebra Capital Management (4)
    Shares Held Directly: --
    Sole Voting Power: --
    Shared Voting Power: 33,457,649
    Sole Dispositive Power: --
    Shared Dispositive Power: 33,457,649
    Beneficial Ownership: 33,457,649
    Percentage of Class: 19.29%(1)

    Reporting Person: Daniel Patrick Gibson (5)
    Shares Held Directly: 714,300
    Sole Voting Power: 714,300
    Shared Voting Power:33,600,549
    Sole Dispositive Power: 714,300
    Shared Dispositive Power: 33,600,549
    Beneficial Ownership: 34,314,849
    Percentage of Class: 19.78%(1)

    (1) This percentage is calculated based upon 173,490,094 shares of the Issuers Common Stock outstanding as computed in accordance with Rule 13d-3(d)(1)(i) promulgated under the Exchange Act.
    (2) Sylebra US holds no shares of the Issuer's Common Stock directly. Sylebra US may be deemed to have beneficial ownership of the shares of the Issuer's Common Stock held by the Affiliated Investment Entities due to its role as their investment sub-adviser.
    (3) Sylebra HK holds no shares of the Issuer's Common Stock directly. Sylebra HK may be deemed to have beneficial ownership of the shares of the Issuer's Common Stock held by the Affiliated Investment Entities due to its role as their investment sub-adviser.
    (4) Sylebra Cayman holds no shares of the Issuer's Common Stock directly. Sylebra Cayman may be deemed to have beneficial ownership of the shares of the Issuer's Common Stock held by the Affiliated Investment Entities due to its role as the investment manager and parent of Sylebra HK.
    (5) Gibson owns 100% of Class A shares of Sylebra Cayman and thus may be deemed to have beneficial ownership of the shares of the Issuer's Common Stock held by the Affiliated Investment Entities. Gibson owns 100% of the outstanding equity interests in GK LLC and thus may be deemed to have beneficial ownership of the shares of the Issuer's Common Stock held by GK LLC.

    (c) Other than as disclosed above, there have been no reportable transactions with respect to the Issuer's Common Stock within the last 60 days by the Reporting Persons other than as described in this Statement.
    (d) No person other than the Reporting Persons has the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the Issuer's Common Stock.
    (e) Not applicable.
    ITEM 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT TO SECURITIES OF THE ISSUER:
    The information provided in Items 3, 4 and 5 is hereby incorporated herein by this reference.
    Except for the Joint Filing Agreement attached hereto as Exhibit 99.1, to the knowledge of the Reporting Persons, there are no contracts, arrangements, understandings or relationships (legal or otherwise) among the Reporting Persons or, to the knowledge of any of the Reporting Persons, any other person or entity referred to in Item 2, or between such persons and any other person, with respect to any securities of the Issuer, including, but not limited to, transfer or voting of any of the securities, finders fees, joint ventures, loan or option arrangements, puts or calls, guarantees of profits, division of profits or loss, or the giving or withholding of proxies.
    ITEM 7. MATERIALS TO BE FILES AS EXHIBITS:
    Exhibit 99.1 Joint Filing Agreement, dated as of 17 September, 2024 by and among the Reporting Persons.
    CUSIP No.: 74623V103
    SIGNATURE
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
    September 17 2024
    Sylebra Capital LLC
    By:
    /s/ Matthew Whitehead
    Name:
    Matthew Whitehead
    Title:
    Authorized Signatory
    September 17 2024
    Sylebra Capital Limited
    By:
    /s/ Matthew Whitehead
    Name:
    Matthew Whitehead
    Title:
    Authorized Signatory
    September 17 2024
    Sylebra Capital Management
    By:
    /s/ Matthew Whitehead
    Name:
    Matthew Whitehead
    Title:
    Authorized Signatory
    September 17 2024
    Daniel Patrick Gibson
    By:
    /s/ Daniel Patrick Gibson
    Name:
    Daniel Patrick Gibson
    Title:
    Individual
    Attention — Intentional misstatements or omissions of fact constitute Federal criminal violations (See 18 U.S.C. 1001).
    CUSIP No.: 74623V103
    The undersigned acknowledge and agree that the foregoing statement on Schedule 13D is filed on behalf of each of the undersigned and that all subsequent amendments to this foregoing shall be filed on behalf of each of the undersigned without the necessity of filing additional joint filing agreements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the others, except to the extent that it knows or has reason to believe that such information is inaccurate.

    This Agreement may be executed in counterparts and each of such counterparts taken together shall constitute one and the same instrument.

    Sylebra Capital LLC
    By: /s/ Matthew Whitehead
    Name: Matthew Whitehead
    Title: Authorized Signatory

    Sylebra Capital Limited
    By: /s/ Matthew Whitehead
    Name: Matthew Whitehead
    Title: Authorized Signatory

    Sylebra Capital Management
    By: /s/ Matthew Whitehead
    Name: Matthew Whitehead
    Title: Authorized Signatory

    Daniel Patrick Gibson
    By: /s/ Daniel Patrick Gibson
    Name: Daniel Patrick Gibson
    Title: Individual

    Date: September 17, 2024
    Get the next $PCT alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $PCT

    DatePrice TargetRatingAnalyst
    5/8/2025$15.00 → $13.00Buy
    TD Cowen
    11/20/2024$10.00 → $15.00Buy
    TD Cowen
    10/18/2024$14.00Overweight
    Cantor Fitzgerald
    8/9/2024$7.50 → $10.00Buy
    TD Cowen
    1/3/2024$4.00Buy → Hold
    Craig Hallum
    12/19/2023$3.00Buy → Neutral
    ROTH MKM
    11/9/2023Outperform → Perform
    Oppenheimer
    9/16/2022$15.00Buy
    Stifel
    More analyst ratings

    $PCT
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Innventure LLC and Learn CW Investment Corporation Announce Filing of Registration Statement on Form S-4 in Connection With Proposed Business Combination

      Innventure LLC, an enterprise growth engine ("Innventure"), and Learn CW Investment Corporation, a special purpose acquisition company (NYSE:LCW) ("Learn CW"), announced today the filing of a registration statement on Form S-4 (the "Registration Statement") with the U.S. Securities and Exchange Commission ("SEC") relating to their previously announced proposed business combination. Learn CW is sponsored by CWAM LC Sponsor LLC, an affiliate of Learn Capital, LLC and Commonwealth Asset Management. The Registration Statement contains a preliminary proxy statement/consent solicitation statement/prospectus in connection with the proposed business combination between Innventure and Learn CW. Wh

      1/29/24 9:00:00 AM ET
      $LCW
      $PCT
      Blank Checks
      Finance
      Major Chemicals
      Industrials
    • PureCycle Technologies, Inc.: Please contact the Portnoy Law Firm to recover your losses; November 28, 2023 deadline.

      Investors can contact the law firm at no cost to learn more about recovering their losses ​LOS ANGELES, Oct. 17, 2023 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises PureCycle Technologies, Inc. ("PureCycle" or the "Company") (NASDAQ:PCT) investors that a lawsuit filed on behalf of investors that purchased PureCycle securities between August 8, 2023 and September 13, 2023, both dates inclusive (the "Class Period"). Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 844-767-8529 or email: [email protected], to discuss their legal rights, or click here to join the case via www.portnoylaw.com. The Portnoy Law Firm can provide a complimentary case evaluation and di

      10/17/23 12:00:00 PM ET
      $PCT
      Major Chemicals
      Industrials
    • PureCycle Technologies, Inc.: Please contact the Portnoy Law Firm to recover your losses; November 28, 2023 deadline

      Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Oct. 13, 2023 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises PureCycle Technologies, Inc. ("PureCycle" or the "Company") (NASDAQ:PCT) investors that a lawsuit filed on behalf of investors that purchased PureCycle securities between August 8, 2023 and September 13, 2023, both dates inclusive (the "Class Period"). Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 844-767-8529 or email: [email protected], to discuss their legal rights, or click here to join the case via www.portnoylaw.com. The Portnoy Law Firm can provide a complimentary case evaluation

      10/13/23 8:45:39 PM ET
      $PCT
      Major Chemicals
      Industrials

    $PCT
    SEC Filings

    See more
    • SEC Form 10-Q filed by PureCycle Technologies Inc.

      10-Q - PureCycle Technologies, Inc. (0001830033) (Filer)

      5/7/25 4:13:15 PM ET
      $PCT
      Major Chemicals
      Industrials
    • PureCycle Technologies Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - PureCycle Technologies, Inc. (0001830033) (Filer)

      5/7/25 4:08:15 PM ET
      $PCT
      Major Chemicals
      Industrials
    • PureCycle Technologies Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Material Modification to Rights of Security Holders, Financial Statements and Exhibits

      8-K - PureCycle Technologies, Inc. (0001830033) (Filer)

      4/15/25 4:04:08 PM ET
      $PCT
      Major Chemicals
      Industrials

    $PCT
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Large owner Sylebra Capital Llc bought $4,996,596 worth of shares (619,925 units at $8.06) (SEC Form 4)

      4 - PureCycle Technologies, Inc. (0001830033) (Issuer)

      2/10/25 8:19:12 AM ET
      $PCT
      Major Chemicals
      Industrials
    • Large owner Sylebra Capital Llc bought $20,000,003 worth of shares (4,264,393 units at $4.69) (SEC Form 4)

      4 - PureCycle Technologies, Inc. (0001830033) (Issuer)

      9/16/24 10:54:13 AM ET
      $PCT
      Major Chemicals
      Industrials
    • Musa Fernando bought $99,934 worth of shares (18,303 units at $5.46) (SEC Form 4) (Amendment)

      4/A - PureCycle Technologies, Inc. (0001830033) (Issuer)

      4/2/24 8:09:45 PM ET
      $PCT
      Major Chemicals
      Industrials

    $PCT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by PureCycle Technologies Inc.

      SC 13G/A - PureCycle Technologies, Inc. (0001830033) (Subject)

      9/20/24 5:18:10 PM ET
      $PCT
      Major Chemicals
      Industrials
    • Amendment: SEC Form SC 13D/A filed by PureCycle Technologies Inc.

      SC 13D/A - PureCycle Technologies, Inc. (0001830033) (Subject)

      9/17/24 11:35:20 AM ET
      $PCT
      Major Chemicals
      Industrials
    • SEC Form SC 13G/A filed by PureCycle Technologies Inc. (Amendment)

      SC 13G/A - PureCycle Technologies, Inc. (0001830033) (Subject)

      2/14/24 1:46:40 PM ET
      $PCT
      Major Chemicals
      Industrials

    $PCT
    Financials

    Live finance-specific insights

    See more
    • PureCycle Technologies Schedules Second Quarter 2023 Corporate Update Conference Call for Wednesday, August 9, 2023, at 11:00 a.m. ET

      ORLANDO, FL / ACCESSWIRE / July 19, 2023 / PureCycle Technologies, Inc. (NASDAQ:PCT), a U.S.-based company revolutionizing plastic recycling, will host a conference call on Wednesday, August 9, 2023, to provide an update on recent corporate developments. A press release discussing such developments and other activity from the second quarter will be provided prior to the conference call.Second Quarter 2023 Conference Call DetailsDate: Wednesday, August 9, 2023Time: 11:00 a.m. ETParticipant Registration: [Click Here]For participants interested in a listen-only webcast, please register for the conference call using the above link in advance of the call start time. For analyst participants who w

      7/19/23 4:05:00 PM ET
      $PCT
      Major Chemicals
      Industrials
    • PureCycle Technologies Schedules First Quarter 2023 Corporate Update Conference Call for Tuesday, May 9, 2023, at 4:00 p.m. ET

      ORLANDO, Fla., April 26, 2023 /PRNewswire/ -- PureCycle Technologies, Inc. (NASDAQ:PCT), a U.S.-based company revolutionizing plastic recycling, will host a conference call on Tuesday, May 9, 2023, to provide an update on recent corporate developments. A press release discussing such developments and other activity from the first quarter will be provided prior to the conference call. First Quarter 2023 Conference Call Details Date:                                                      Tuesday, May 9, 2023 Time:                                                     4:00 p.m. ET  P

      4/26/23 4:05:00 PM ET
      $PCT
      Major Chemicals
      Industrials
    • PureCycle Technologies Schedules Fourth Quarter 2022 Corporate Update Conference Call for Thursday, March 16, 2023, at 10:00 a.m. ET

      ORLANDO, Fla., March 10, 2023 /PRNewswire/ -- PureCycle Technologies, Inc. (NASDAQ:PCT), a U.S.-based company revolutionizing plastic recycling, will host a conference call on Thursday, March 16, 2023, to provide an update on recent corporate developments, specifically where we are in the process of mechanical completion and start-up commissioning of our flagship purification facility in Ironton, Ohio. A press release discussing such developments and other activity from the fourth quarter will be provided prior to the conference call. Fourth Quarter 2022 Conference Call Detail

      3/10/23 8:00:00 AM ET
      $PCT
      Major Chemicals
      Industrials

    $PCT
    Leadership Updates

    Live Leadership Updates

    See more
    • PureCycle Technologies, Inc.: Please contact the Portnoy Law Firm to recover your losses; November 28, 2023 deadline.

      Investors can contact the law firm at no cost to learn more about recovering their losses ​LOS ANGELES, Oct. 17, 2023 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises PureCycle Technologies, Inc. ("PureCycle" or the "Company") (NASDAQ:PCT) investors that a lawsuit filed on behalf of investors that purchased PureCycle securities between August 8, 2023 and September 13, 2023, both dates inclusive (the "Class Period"). Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 844-767-8529 or email: [email protected], to discuss their legal rights, or click here to join the case via www.portnoylaw.com. The Portnoy Law Firm can provide a complimentary case evaluation and di

      10/17/23 12:00:00 PM ET
      $PCT
      Major Chemicals
      Industrials
    • PureCycle Technologies, Inc.: Please contact the Portnoy Law Firm to recover your losses; November 28, 2023 deadline

      Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Oct. 13, 2023 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises PureCycle Technologies, Inc. ("PureCycle" or the "Company") (NASDAQ:PCT) investors that a lawsuit filed on behalf of investors that purchased PureCycle securities between August 8, 2023 and September 13, 2023, both dates inclusive (the "Class Period"). Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 844-767-8529 or email: [email protected], to discuss their legal rights, or click here to join the case via www.portnoylaw.com. The Portnoy Law Firm can provide a complimentary case evaluation

      10/13/23 8:45:39 PM ET
      $PCT
      Major Chemicals
      Industrials

    $PCT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Coombs Daniel M was granted 19,349 shares, increasing direct ownership by 16% to 140,221 units (SEC Form 4)

      4 - PureCycle Technologies, Inc. (0001830033) (Issuer)

      5/9/25 4:05:38 PM ET
      $PCT
      Major Chemicals
      Industrials
    • Director Musa Fernando was granted 19,349 shares, increasing direct ownership by 33% to 77,166 units (SEC Form 4)

      4 - PureCycle Technologies, Inc. (0001830033) (Issuer)

      5/9/25 4:03:54 PM ET
      $PCT
      Major Chemicals
      Industrials
    • Director Bouck Steven F was granted 19,349 shares, increasing direct ownership by 29% to 85,166 units (SEC Form 4)

      4 - PureCycle Technologies, Inc. (0001830033) (Issuer)

      5/9/25 4:02:32 PM ET
      $PCT
      Major Chemicals
      Industrials

    $PCT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • TD Cowen reiterated coverage on PureCycle Technologies with a new price target

      TD Cowen reiterated coverage of PureCycle Technologies with a rating of Buy and set a new price target of $13.00 from $15.00 previously

      5/8/25 6:55:04 AM ET
      $PCT
      Major Chemicals
      Industrials
    • TD Cowen reiterated coverage on PureCycle Technologies with a new price target

      TD Cowen reiterated coverage of PureCycle Technologies with a rating of Buy and set a new price target of $15.00 from $10.00 previously

      11/20/24 8:09:41 AM ET
      $PCT
      Major Chemicals
      Industrials
    • Cantor Fitzgerald initiated coverage on PureCycle Technologies with a new price target

      Cantor Fitzgerald initiated coverage of PureCycle Technologies with a rating of Overweight and set a new price target of $14.00

      10/18/24 7:40:00 AM ET
      $PCT
      Major Chemicals
      Industrials